Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines

International Journal of Cancer

Volumn 107, Issue 1, 2003, Pages 53-59

  Fukami, Takeshi ^a   Fukuhara, Hiroshi ^a   Kuramochi, Masami ^a   Maruyama, Tomoko ^a   Isogai, Kana ^a   Sakamoto, Michiie ^b   Takamoto, Shinichi ^a   Murakami, Yoshinori ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Bi allelic methylation; Nonsmall cell lung cancer; Promoter methylation; TSLC1; Tumor suppressor gene

Indexed keywords

BISULFITE; IMMUNOGLOBULIN;

ALLELE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CLASSIFICATION; CELL ADHESION; COLORECTAL CANCER; CPG ISLAND; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LUNG TUMOR; METHYLATION; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; STOMACH CANCER; TSLC1 GENE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; ALLELES; BRAIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOGLOBULINS; LOSS OF HETEROZYGOSITY; LUNG; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICROSATELLITE REPEATS; NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0042916159     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11348     Document Type: Article

References (28)

1. Doyle R. Lung cancer in U.S. males. Sci Am 1997;276:28.
2. Ihde DC, Minna JD. Non-small cell lung cancer. Part I: Biology, diagnosis, and staging. Curr Probl Cancer 1991;15:61-104.
3. Birrer MJ, Minna JD. Genetic changes in the pathogenesis of lung cancer. Annu Rev Med 1989;40:305-17.
4. Yuasa Y, Srivastava SK, Dunn CY, Rhim JS, Reddy EP, Aaronson SA. Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature 1983;303:775-9.
5. Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Della Porta G, Barbacid M. Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Science 1984;223:661-4.
6. Suzuki Y, Orita M, Shiraishi M, Hayashi K, Sekiya T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990;5:1037-43.
7. Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD. p53: a frequent target for genetic abnormalities in lung cancer. Science 1989;246:491-4.
8. Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H, Gazdar AF, Minna JD. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 1990;5:1603-10.
9. Kishimoto Y, Murakami Y, Shiraishi M, Hayashi K, Sekiya T. Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung. Cancer Res 1992;52:4799-804.
10. Sachse R, Murakami Y, Shiraishi M, Hayashi K, Sekiya T. DNA aberrations at the retinoblastoma gene locus in human squamous cell carcinomas of the lung. Oncogene 1994;9:39-47.
11. Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J, Evans GA. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 1998;282:284-7.
12. Kok K, Osinga J, Carritt B, Davis MB, van der Hout AH, van der Veen AY, Landsvater RM, de Leij LF, Berendsen HH, Postmus PE, Poppema S, Buys CHCM. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 1987;330:578-81.
13. Weston A, Willey JC, Modali R, Sugimura H, McDowell EM, Resau J, Light B, Haugen A, Mann DL, Trurnp BF, Harris CC. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung. Proc Natl Acad Sci USA 1989;86:5099-103.
14. Iizuka M, Sugiyama Y, Shiraishi M, Jones C, Sekiya T. Allelic losses in human chromosome 11 in lung cancers. Genes Chromosomes Cancer 1995;13:40-6.
15. Tamura K, Zhang X, Murakami Y, Hirohashi S, Xu HJ, Hu SX, Benedict WF, Sekiya T. Deletion of three distinct regions on chromosome 13q in human non-small-cell lung cancer. Int J Cancer 1997;74:45-9.
16. Murakami Y, Nobukuni T, Tamura K, Maruyama T, Sekiya T, Arai Y, Gomyou H, Tanigami A, Ohki M, Cabin D, Frischmeyer P, Hunt P, et al. Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q. Proc Natl Acad Sci USA 1998;95:8153-8.
17. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP, Pletcher M, Isomura M, Onizuka M, Kitamura T, Sekiya T, Reeves RH, et al. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 2001;27:427-30.
18. Gomyo H, Arai Y, Tanigami A, Murakami Y, Hattori M, Hosoda F, Arai K, Aikawa Y, Tsuda H, Hirohashi S, Asakawa S, Shimizu N, et al. A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2. Genomics 1999;62:139-46.
19. Masuda M, Yageta M, Fukuhara H, Kuramochi M, Maruyama T, Nomoto A, Murakami Y. The tumor suppressor protein TSLC1 is involved in cell-cell adhesion. J Biol Chem 2002;277:31014-9.
20. Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, Shibuya T, Murakami M. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res 2002;62:5129-33.
21. Fukuhara H, Kuramochi M, Fukami T, Kasahara K, Furuhata M, Nobukuni T, Maruyama T, Isogai K, Sekiya T, Shuin T, Kitamura T, Reeves RH, et al. Promoter methylation of the TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res 2002;93:605-9.
22. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992;89:1827-31.
23. Veigl ML, Kasturi L, Olechnowicz J, Ma AH, Lutterbaugh JD, Periyasamy S, Li GM, Drummond J, Modrich PL, Sedwick WD, Markowitz SD. Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 1998;95:8698-702.
24. Kawanishi M, Kohno T, Otsuka T, Adachi J, Sone S, Noguchi M, Hirohashi S, Yokota J. Allelotype and replication error phenotype of small cell lung carcinoma. Carcinogenesis 1997;18:2057-62.
25. Burri N, Chaubert P. Complex methylation patterns analyzed by single-strand conformation polymorphism. Biotechniques 1999;26: 232-4.
26. Maekawa M, Sugano K, Kashiwabara H, Ushiama M, Fujita S, Yoshimori M, Kakizoe T. DNA methylation analysis using bisulfite treatment and PCR-single-strand conformation polymorphism in colorectal cancer showing microsatellite instability. Biochem Biophys Res Commun 1999;262:671-6.
27. Allinen M, Peri L, Kujala S, Lahti-Domenici J, Outila K, Karppinen SM, Launonen V, Winqvist R. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer 2000;34: 384-9.
28. Yang Q, Mori I, Shan L, Nakamura M, Nakamura Y, Utsunomiya H, Yoshimura G, Suzuma T, Tamaki T, Umemura T, Sakurai T, Kakudo K. Inactivation of retinoic acid receptor beta2 gene by epigenetic change in breast cancer. Am J Pathol 2001;158:299-303.